Singh Sarvinder
Consultant (Med & Resp Med), Army Hospital (R&R), Delhi Cantt 110010, India.
Med J Armed Forces India. 2021 Jan;77(1):82-85. doi: 10.1016/j.mjafi.2020.05.007. Epub 2020 Jul 13.
Bronchial hyper-responsiveness (BHR) is the hallmark of bronchial asthma, characterized by clinical features of cough, wheeze, breathlessness and chest tightness which are confirmed by spirometry showing obstructive pattern and reversibility to bronchodilators. In individuals having features of bronchial asthma but normal spirometry, demonstration of BHR with bronchial challenge test (direct or indirect) confirms/ rules out the diagnosis. The aim of this study was to assess BHR in patients (methacholine challenge) with a history suggestive of bronchial asthma but normal spirometry and its role in diagnosis of bronchial asthma.
This study was conducted at tertiary care respiratory center. Patients having clinical features of bronchial asthma but spirometry not confirming obstructive disorder and or reversibility were included in the study. After written consent, methacholine challenge test with methacholine chloride and exercise spirometry was done in all patients as per the American Thoracic Society protocol.
A total of 50 (n) patients were included in the study. Among them, 42 patients had clinical features suggestive of bronchial asthma but having normal spirometry and eight patients were diagnosed as they had bronchial asthma in the past but asymptomatic and off drugs were included in the study. At PC20 4mg/ml 32 (64%) patients had a positive test, 28(66%) symptomatic patients and four (50%) asymptomatic asthmatics. There were no significant side effects with methacholine test.
Airway hyper-responsiveness is an important aspect of bronchial asthma and its demonstration with bronchial challenge (direct and indirect) test is an important diagnostic tool. Methacholine challenge test is a safe procedure to perform under supervision.
支气管高反应性(BHR)是支气管哮喘的标志,其临床特征为咳嗽、喘息、气促和胸闷,通过肺功能测定显示阻塞性模式且对支气管扩张剂有可逆性来确诊。在具有支气管哮喘特征但肺功能正常的个体中,通过支气管激发试验(直接或间接)证明BHR可确诊/排除诊断。本研究的目的是评估有支气管哮喘病史但肺功能正常的患者(乙酰甲胆碱激发试验)的BHR及其在支气管哮喘诊断中的作用。
本研究在三级护理呼吸中心进行。具有支气管哮喘临床特征但肺功能测定未证实阻塞性疾病和/或可逆性的患者纳入研究。在获得书面同意后,按照美国胸科学会方案对所有患者进行氯化乙酰甲胆碱激发试验和运动肺功能测定。
共有50名患者纳入研究。其中,42名患者具有支气管哮喘的临床特征但肺功能正常,8名患者曾被诊断为支气管哮喘但无症状且已停药,纳入研究。在PC20为4mg/ml时,32名(64%)患者试验呈阳性,28名(66%)有症状患者和4名(50%)无症状哮喘患者。乙酰甲胆碱试验无明显副作用。
气道高反应性是支气管哮喘的一个重要方面,通过支气管激发(直接和间接)试验证明气道高反应性是一种重要的诊断工具。乙酰甲胆碱激发试验在监督下进行是一种安全的操作。